Literature DB >> 11165815

Protein C-loaded monomethoxypoly (ethylene oxide)-poly(lactic acid) nanoparticles.

M F Zambaux1, F Bonneaux, R Gref, E Dellacherie, C Vigneron.   

Abstract

This paper deals with the preparation and characterization of monomethoxypoly(ethylene oxide)-poly(lactic acid) (MPEO-PLA) nanoparticles containing protein C, a plasma inhibitor which regulates the mechanism of blood coagulation. Protein C was entrapped in MPEO-PLA nanoparticles using the double emulsion method. The influence of MPEO-PLA copolymers on the different parameters was evaluated: characteristics of protein C-loaded nanoparticles, in vitro release of the protein, evolution of the particle size with incubation time and MPEO release. The nanoparticle size does not depend on copolymer characteristics (MPEO and/or PLA block molecular weight). On the other hand, the efficiency of protein C entrapment is affected by the copolymer characteristics. The burst effect during the protein C release is increased with the hydrophilic character of the copolymer. Moreover, protein C adsorption on the particle surface during its release may be related to MPEO release. Only 25% of the released protein C is active, which clearly illustrates that it is altered during its encapsulation. The optimization of the experimental parameters which disturbed entrapped protein C activity, i.e. sonication time and organic solvent was investigated and has led to a preservation of protein C activity. Then, to optimize its entrapment efficiency, a blend PLA/MPEO-PLA (25/75) was used to prepare nanoparticles. This blend limited burst effect of protein C and its adsorption. However, protein C is only partially released which implicates further investigation for a potential therapeutic use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165815     DOI: 10.1016/s0378-5173(00)00548-2

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

2.  Synthesis of pegylated immunonanoparticles.

Authors:  Jean-Christophe Olivier; Ramon Huertas; Hwa Jeong Lee; Frederic Calon; William M Pardridge
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

3.  PEG-PLA Nanocapsules Containing a Nanobiotechnological Complex of Polyhemoglobin-Tyrosinase for the Depletion of Tyrosine in Melanoma: Preparation and In Vitro Characterisation.

Authors:  Caroline Fustier; Thomas M S Chang
Journal:  J Nanomedine Biotherapeutic Discov       Date:  2012-03

4.  Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations.

Authors:  Xiao Hu; Feifei Yang; Yonghong Liao; Lin Li; Lan Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain.

Authors:  Xin-hua Tian; Feng Wei; Tian-xiao Wang; Peng Wang; Xiao-ning Lin; Jun Wang; Dong Wang; Lei Ren
Journal:  Int J Nanomedicine       Date:  2012-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.